Showing results (191-200 of 454) with videos related to
Sort By:
Pageof 46
The Journal of Rheumatology|August 18, 2001
Seasonal symptom severity in patients with rheumatic diseases: a study of 1,424 patientsD J Hawley, F Wolfe, F A Lue, et al.Arthritis and Rheumatism|March 1, 1997
Increased rates of fibromyalgia following cervical spine injury. A controlled study of 161 cases of traumatic injuryD Buskila, L Neumann, G Vaisberg, et al.Osteoarthritis and Cartilage|March 15, 2011
OARSI-FDA initiative: defining the disease state of osteoarthritisN E Lane, K Brandt, G Hawker, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 12, 1998
Acute changes in trabecular bone connectivity and osteoclast activity in the ovariectomized rat in vivoN E Lane, J M Thompson, D Haupt, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 20, 2016
Thoracic kyphosis and rate of incident vertebral fractures: the Fracture Intervention TrialW B Katzman, E Vittinghoff, D M Kado, et al.The Journal of Clinical Investigation|October 28, 1998
Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trialN E Lane, S Sanchez, G W Modin, et al.Arthritis and Rheumatism|January 30, 2010
Association of 25-hydroxyvitamin D with prevalent osteoarthritis of the hip in elderly men: the osteoporotic fractures in men studyR K Chaganti, N Parimi, P Cawthon, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 10, 2000
Bone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: results of a randomized controlled clinical trialN E Lane, S Sanchez, G W Modin, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 25, 2020
Real-world bone turnover marker use: impact on treatment decisions and fractureN E Lane, K Saag, T J O'Neill, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 28, 2003
Basic fibroblast growth factor forms new trabeculae that physically connect with pre-existing trabeculae, and this new bone is maintained with an anti-resorptive agent and enhanced with an anabolic agent in an osteopenic rat modelN E Lane, J Kumer, W Yao, et al.Pageof 46